Rekombinante proteiner

Phenylmethylsulfonyl fluoride (PMSF) is a non-specific inhibitor of serine proteases and the cysteine protease papain (reversible by DTT treatment). PMSF does not inhibit metalloproteases, most cysteine proteases or aspartic proteases.

A synthetic peptide derived from Histone H3.1, amino acids 21-44, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) from the rest of the peptide sequence. Accurate UV quantification is done based on internal Tyr. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

A synthetic peptide derived from Histone H3.1, amino acids 21-44, modified with an acetyl group on lysine 27, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) from the rest of the peptide sequence. Accurate UV quantification is done based on internal Tyr. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

A synthetic peptide derived from Histone H3.1, amino acids 21-44, modified by methylation on lysine 27, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) from the rest of the peptide sequence. Accurate UV quantification is done based on internal Tyr. The presence of the lysine residue is for quantitation and does not affect peptide functionality

A synthetic peptide derived from Histone H3.1, amino acids 21-44, modified by methylation on lysine 27, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) from the rest of the peptide sequence. Accurate UV quantification is done based on internal Tyr. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

A synthetic peptide derived from Histone H3.1, amino acids 21-44, modified by methylation on lysine 27, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) from the rest of the peptide sequence. Accurate UV quantification is done based on internal Tyr. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

A synthetic peptide derived from Histone H3.1, amino acids 1-21, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) and one Tyr (provides accurate UV quantification) from the rest of the peptide sequence. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

A synthetic peptide derived from Histone H3.1, amino acids 1-21, modified with an acetyl group on lysine 4, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) and one Tyr (provides accurate UV quantification) from the rest of the peptide sequence. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

A synthetic peptide derived from Histone H3.1, amino acids 1-21, modified by methylation on lysine 4, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) and one Tyr (provides accurate UV quantification) from the rest of the peptide sequence. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

A synthetic peptide derived from Histone H3.1, amino acids 1-21, modified by methylation on lysine 4, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) and one Tyr (provides accurate UV quantification) from the rest of the peptide sequence. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

A synthetic peptide derived from Histone H3.1, amino acids 1-21, modified by methylation on lysine 4, with an added lysine residue containing a biotin moiety and a C-terminal amide group (CONH2). C-term biotinylated Lys residue is separated with two Gly (provide short spacer) and one Tyr (provides accurate UV quantification) from the rest of the peptide sequence. The presence of the lysine residue is for quantitation and does not affect peptide functionality.

Recombinant BRD4 protein that includes full length of human BRD4 protein (accession number NP_055114.1) was expressed in Sf9 cells and contains an N-terminal FLAG tag with a molecular weight of 81.7 kDa. The purity of the protein is ≥ 95% by SDS-PAGE.